Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04446169
Other study ID # 17104_oss/2020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 27, 2020
Est. completion date September 2, 2021

Study information

Verified date October 2021
Source University of Florence
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is part of the current global emergency scenario due to infection with Coronavirus, SARS-CoV-2 as indicated by the international taxonomy. Study aim is to investigate the possibility of the presence of the virus within the seminal fluid and in the urine of infected patients, both during the acute phase and remotely. Current evidences show that Coronaviruses can be present inside the testicle and sperm in other species, such as in feline and avian models. In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab. Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine. A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer. The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind. The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.


Description:

This study is part of the current global emergency scenario due to infection with Coronavirus, SARS-CoV-2 as indicated by the international taxonomy. Study aim is to investigate the possibility of the presence of the virus within the seminal fluid and in the urine of infected patients, both during the acute phase and remotely. Current evidences show that Coronaviruses can be present inside the testicle and sperm in other species, such as in feline and avian models. In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab. Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine. A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer. According to results obtained, follow up will be tailored to patients (assessment for COVID 19 infections and/or further analysis/folliow-up in case of abnormal findings) The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind. The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.


Recruitment information / eligibility

Status Completed
Enrollment 43
Est. completion date September 2, 2021
Est. primary completion date September 1, 2020
Accepts healthy volunteers
Gender Male
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Male Sex - Age>18 years - Will to participate to the study - Documented past infection for SARS-CoV2 (Nasopharyngeal swab positive for SARS-CoV2 RNA) - Current negative infection for SARS-CoV2 (Two negative Nasopharyngeal swab for SARS-CoV2 RNA, done following WHO guidelines) Exclusion Criteria: - Age more than 80 years old - Anejaculation - Patient's will

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
SARS-CoV 2 RNA PCR Urine
Search for SARS-CoV 2 RNA in urine through PCR
SARS-CoV 2 RNA PCR Semen
Search for SARS-CoV 2 RNA in Semen through PCR
Semen Qualitative Analysis
Search for Semen Alterations in patients with past SARS-CoV 2 infection
IIEF-5 questionnaire
IIEF-5 assessment in patients with past SARS-CoV 2 infection
Male Sexual Health Questionnaire (MSHQ)
Male Sexual Health Questionnaire (MSHQ) assessment in patients with past SARS-CoV 2 infection
IPSS questionnaire
IPSS assessment in patients with past SARS-CoV 2 infection
SECRET questionnaire
SECRET questionnaire assessment in patients with past SARS-CoV 2 infection
Interleukin assessment in semen
Assessment of Interleukin presence and quantitative analysis in semen, to study if a previous inflammation/infection due to SARS-CoV 2 in testis was present

Locations

Country Name City State
Italy AOU Careggi Florence Tuscany

Sponsors (2)

Lead Sponsor Collaborator
University of Florence Azienda Ospedaliero-Universitaria Careggi

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary SARS-CoV 2 presence in semen SARS-CoV 2 RNA PCR in semen Enrollment
Primary SARS-CoV 2 presence in urine SARS-CoV 2 RNA PCR in urine Enrollment
Primary Inflammation in Semen Interleukin quantitative analysis in Semen, to assess if past inflammation due to SARS-CoV 2 Infection was present Enrollment
Primary Semen quantitative and qualitative analysis Spermiogram done following WHO guidelines and criteria Enrollment
Secondary Erectile Function International Index of Erectile Function (IIEF-5) questionnaire administration. Score range from 0 to 25. Higher scores mean good erectile function Enrollment
Secondary Sexual Habits SExual Chronicle REcording Table (SECRET) questionnaire administration Questionnaire helps to assess the sexual habits of individuals Enrollment
Secondary Urinary function International Prostate Symptom Score (IPSS) questionnaire administration Score range from 0 to 35. Higher scores mean worst urinary function Enrollment
Secondary Sexual and Ejaculatory Function Male Sexual Health Questionnaire Short Form (MSHQ-SF) admnistration Higher scores mean better sexual and ejaculatory function Enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT04410510 - P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 Phase 2/Phase 3
Withdrawn NCT04456426 - Characteristics of Patients With COVID-19 in Meta State, Colombia
Suspended NCT04385771 - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation N/A
Terminated NCT04435457 - Cardiovascular Implications of COVID-19
Withdrawn NCT04386447 - Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19 Phase 2
Completed NCT04357834 - WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
Completed NCT04405934 - COG-UK Project Hospital-Onset COVID-19 Infections Study N/A
Completed NCT04615936 - Nasal Photodisinfection COVID-19 Proof of Concept Study N/A
Completed NCT04369794 - COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement Phase 4
Terminated NCT04401410 - Anti-SARS Cov-2 T Cell Infusions for COVID 19 Phase 1
Completed NCT04542850 - Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19 N/A
Completed NCT04382040 - A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 Phase 2
Completed NCT04366908 - Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome Phase 2
Completed NCT04378582 - Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU
Completed NCT04383587 - Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers N/A
Recruiting NCT04402814 - IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.
Completed NCT04374565 - Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia Phase 2
Completed NCT04395924 - Maternal-foetal Transmission of SARS-Cov-2
Completed NCT04425889 - COVID-19 Antibodies Among Healthcare Workers
Completed NCT04413071 - Cardiac COVID-19 Health Care Workers